PPAR-γ Activation Alleviates Osteoarthritis through Both the Nrf2/NLRP3 and PGC-1α/Δψ m Pathways by Inhibiting

Zhencheng Feng1, Qiuxiang Huang2, Xingliang Zhang3,4

  • 1Department of Orthopedics, Guangzhou Red Cross Hospital, Jinan University, Guangzhou 51022, China.

PPAR Research
|April 6, 2023
PubMed

Insights

Pioglitazone (Piog) activation of PPAR-gamma suppresses pyroptosis in osteoarthritis (OA) cartilage by enhancing Nrf2/NLRP3 and PGC1-alpha/Δψm pathways, offering a potential treatment for OA.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Rheumatology

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease with increasing incidence in aging and obese populations.
  • Emerging evidence suggests pyroptosis plays a role in OA pathogenesis, identifying it as a potential therapeutic target.
  • The precise relationship between peroxisome proliferator-activated receptor gamma (PPAR-γ) and NLRP3-mediated pyroptosis in OA cartilage remains unclear.

Purpose of the Study:

  • To investigate the role of PPAR-γ in regulating NLRP3-mediated pyroptosis in OA cartilage.
  • To elucidate the underlying molecular mechanisms connecting PPAR-γ activation to pyroptosis suppression in OA.
  • To evaluate the therapeutic potential of pioglitazone (Piog) in OA models.

Main Methods:

  • Analysis of NLRP3-mediated pyroptosis levels in human OA cartilage samples with varying severity.
  • In vitro studies using lipopolysaccharide (LPS)/adenosine triphosphate (ATP)-induced primary chondrocytes.
  • In vivo studies utilizing knee OA rat models.
  • Pharmacological intervention with pioglitazone (Piog) and pathway inhibitors (Nrf2/NLRP3, PGC1-α/Δψm).

Main Results:

  • Higher levels of NLRP3-mediated pyroptosis were observed in severe OA cartilage compared to mild OA cartilage.
  • Pioglitazone (Piog) activation of PPAR-γ attenuated LPS/ATP-induced chondrocyte pyroptosis and arthritis in rat models.
  • The protective effects of Piog were partially reversed by inhibiting the Nrf2/NLRP3 or PGC-1α/Δψm pathways.
  • Complete abrogation of Piog's protective effects occurred when both pathways were simultaneously inhibited.

Conclusions:

  • Pioglitazone (Piog) protects OA cartilage from pyroptosis-induced damage by simultaneously activating the Nrf2/NLRP3 and PGC-1α/Δψm signaling pathways.
  • These activated pathways enhance antioxidative and anti-inflammatory responses and promote mitochondrial biogenesis.
  • Pioglitazone (Piog) shows promise as a potential therapeutic agent for human OA cartilage damage.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K